Appendix Cancer Surgery in Ankara, Turkey

Appendix cancer surgery aims to remove tumor-bearing tissue surgically. In cases diagnosed early, removing only the appendix may be sufficient, while in advanced-stage cases, part of the intestines may also need to be removed. This approach improves survival.

Surgical strategies in appendix cancer treatment are determined by the size of the tumor and the extent of spread. Minimally invasive laparoscopic methods can shorten recovery time while reducing the risk of complications. The patient’s overall health status and oncologic criteria guide the treatment plan.

Follow-up after appendix cancer surgery is extremely important to monitor the risk of metastasis. Regular imaging and laboratory tests allow possible recurrences to be detected early. In addition, adjuvant oncologic treatments such as chemotherapy may be applied when necessary.

Quality of life after appendix cancer surgery is maintained with early mobilization and a well-managed nutritional plan. The patient is closely monitored in the postoperative period to prevent complications. With a multidisciplinary approach, treatment outcomes are supported in a positive direction.

You can contact Prof. Dr. Ebru Soy, one of the doctors performing Appendix Cancer Surgery in Ankara, to get information about Appendix Cancer Surgery prices, the process, and the hospital where Appendix Cancer Surgery is performed.

What Is Appendix Cancer Surgery?

Although appendix cancers are rare, they represent a diverse group of tumors with very different behaviors. For this reason, surgical treatment options are shaped by this diversity. Broadly, we can describe three main surgical approaches.

• Removal of the Appendix Only (Appendectomy): Many appendix cancers are found incidentally in patients who undergo emergency surgery for acute appendicitis after presenting with severe abdominal pain. The cancer diagnosis is made when the removed appendix is examined under a microscope by pathology. If the tumor is detected at a very early stage and its type and features are favorable, this first operation—removing only the appendix—may be sufficient as definitive treatment.
• Removal of Part of the Colon (Right Hemicolectomy): This is a larger cancer operation. It is planned when appendectomy alone is considered insufficient. In this procedure, not only the appendix but also the beginning of the large intestine (cecum), the portion of the colon that ascends toward the liver (ascending colon), and the last segment of the small intestine are removed en bloc together with the regional lymph nodes. The main purpose is to clear regional lymph nodes where cancer may have spread. This helps clarify the true stage and eliminates the risk of local recurrence in that region.
• Abdominal Tumor Clearance and Heated Chemotherapy (Cytoreductive Surgery and HIPEC): This is an advanced, highly specialized treatment used when the disease has spread to the peritoneum (the lining of the abdominal cavity). It is considered the gold-standard treatment especially for “pseudomyxoma peritonei” (PMP), where mucinous appendix tumors spread within the abdomen and a jelly-like fluid accumulates. The treatment has two main stages: first, all visible tumors in the abdomen are meticulously removed surgically—much like removing weeds from a garden. This may require stripping parts of the peritoneum and sometimes removing involved organs such as the spleen, gallbladder, or in women, the uterus and ovaries. The goal is to leave no visible tumor behind. Immediately afterward, while the patient is still under anesthesia, a heated chemotherapy agent (41–43°C) is circulated throughout the abdominal cavity for about 90 minutes using a special machine. Heat itself helps kill cancer cells and enhances the effect of the chemotherapy, aiming to eradicate microscopic disease.

In Which Situations Is Appendix Cancer Surgery Performed?

Deciding which patient needs which operation is the most critical point of treatment and is based entirely on the pathology report. Factors such as tumor type, size, and metastatic potential are considered.

Situations where appendectomy alone may be sufficient include:

• Very early-stage tumors called carcinoma in situ (Tis)
• Neuroendocrine tumors (carcinoids) smaller than 2 cm
• Neuroendocrine tumors without spread into the mesoappendix
• Some very early-stage (T1), low-grade adenocarcinomas without vascular invasion

Situations where a more extensive right hemicolectomy is generally required include higher regional spread risk:

• All neuroendocrine tumors larger than 2 cm
• Goblet cell adenocarcinoma (GCA)
• Signet ring cell carcinoma (SRCC)
• Most mucinous and non-mucinous adenocarcinomas (except very early, low-risk cases)
• Tumors reaching the muscular layer of the appendix wall or deeper (T2 and higher)
• Presence of lymphovascular or perineural invasion on pathology
• Positive surgical margins after the initial appendectomy

Cytoreductive surgery and HIPEC (CRS + HIPEC) are considered when disease has extended beyond the appendix and spread within the abdomen:

• Peritoneal metastasis
• Pseudomyxoma peritonei (PMP)
• No spread to extra-abdominal organs such as the lungs or intraparenchymal liver
• The patient’s overall health is good enough to tolerate major surgery

What Are the Risks of Appendix Cancer Surgery?

As with any surgical procedure, appendix cancer operations carry potential risks. The magnitude of these risks varies significantly depending on the extent of the planned surgery.

General risks that may be encountered in standard operations such as appendectomy or right hemicolectomy include:

• Surgical site infection
• Intra-abdominal abscess
• Bleeding during or after surgery
• Leakage from the bowel connection (anastomotic leak)
• Blood clots in the leg veins (deep vein thrombosis)
• Clot traveling to the lungs (pulmonary embolism)
• General risks related to anesthesia

Cytoreductive surgery and heated chemotherapy (CRS + HIPEC) represent a much larger physiologic stress and therefore carry higher and more varied risks. Performing this operation in high-volume centers with experienced teams is a key part of risk management. Potential risks specific to CRS + HIPEC include:

• Higher rates of bleeding and infection
• Leakage of bowel or gastric contents into the abdomen (fistula)
• Prolonged postoperative ileus (temporary bowel paralysis)
• Bone marrow suppression and lowered blood counts related to chemotherapy
• Temporary or permanent impairment of kidney function
• Fluid and electrolyte imbalances
• Pneumonia or other respiratory complications
• Need for prolonged intensive care stay

How Is Appendix Cancer Surgery Performed?

The surgical technique differs depending on the planned procedure.

Right Hemicolectomy: This surgery may be performed openly or laparoscopically depending on the patient’s condition. Under general anesthesia, the abdomen is entered through an incision. The surgeon carefully separates the bowel segment that includes the appendix base, the cecum, and the ascending colon from surrounding tissues. The main blood vessels supplying this region are tied and divided at their origin together with the lymphatic tissue, ensuring removal of the relevant lymph nodes. Removing at least 12 lymph nodes is generally targeted for accurate staging. After the segment is removed, a new connection (anastomosis) is created between the end of the small intestine and the remaining colon to restore continuity of the digestive tract.

Cytoreductive Surgery (CRS) and HIPEC: This operation is longer, more detailed, and performed in stages, often lasting 6 to 12 hours.

It begins with a long midline abdominal incision. First, all abdominal organs and surfaces are systematically examined. A scoring system called the Peritoneal Cancer Index (PCI) is used to objectively measure disease extent and help the surgeon estimate complexity and the likelihood of complete cytoreduction.

Then comes the main tumor-clearing phase (cytoreduction). The goal is to remove all visible tumor from the abdomen. This may require stripping portions of the peritoneum from the abdominal wall, under the diaphragm, or within the pelvis. The omentum (fatty apron) is typically removed. If the tumor involves the spleen, gallbladder, or in women the uterus and ovaries, these may also need to be removed. Surgical success is measured by achieving complete cytoreduction—leaving no visible tumor behind.

After tumor clearance, special tubes are placed into the abdomen and the skin may be temporarily closed. These tubes are connected to a device that heats and circulates chemotherapy within the abdominal cavity. A common agent such as Mitomycin C is warmed to 41–43°C and circulated for about 90 minutes. Afterward, the drug is drained, the abdomen is rinsed, final checks are performed, and the operation is completed.

Postoperative Process After Appendix Cancer Surgery

Postoperative recovery is proportional to the magnitude of the operation performed.

• After Right Hemicolectomy: Patients usually remain in the hospital for several days. During this time, pain is controlled, diet progresses from liquids to solids, and early mobilization is encouraged. The most important next step after discharge is waiting for the final pathology report. Based on these results—especially if lymph node spread is detected—an oncology team (tumor board) determines whether adjuvant (preventive) chemotherapy is needed.
• After CRS + HIPEC: Following this major surgery, patients are transferred directly to the intensive care unit. Close monitoring is required in the first days to manage the body’s response to extensive surgery. Blood pressure, respiratory status, kidney function, and blood values are continuously tracked. Hospital stay often lasts a few weeks. Recovery at home also requires patience: returning to normal daily activities and regaining prior energy levels may take 6 months to 1 year. Nutritional support, physiotherapy, and motivation are very important during this period.

What Should Patients Pay Attention to After Appendix Cancer Surgery?

In appendix cancer, treatment does not end with surgery. Because this cancer can recur even years later, a regular and potentially lifelong follow-up program is vital. The goal of follow-up is to detect any recurrence at the earliest stage and preserve the chance for effective re-intervention.

Key components of long-term follow-up typically include:

• Regular physician visits
• Monitoring tumor markers in blood tests (CEA, CA 19-9, CA-125)
• Scheduled imaging studies (most commonly CT or MRI)

The frequency and duration of follow-up depend on the initial tumor type and stage. High-risk tumors require closer surveillance in the first years, while low-grade tumors may recur even after many years, so follow-up may extend beyond 10 years.

During follow-up, some warning signs deserve particular attention:

• New or progressively increasing abdominal distension/bloating
• Persistent or unexplained abdominal pain
• Loss of appetite and unintended weight loss
• Marked changes in bowel habits (constipation or diarrhea)
• New, persistent nausea or vomiting

If you experience any of these symptoms, it is important to contact your doctor immediately without waiting for your next scheduled appointment. Remember: your most important partners in this journey are your surgical and oncology teams.